Status:
UNKNOWN
Far Infrared Irradiation for Managing, Control and Treatment of Huntington's Disease (HD)
Lead Sponsor:
GAAD Medical Research Institute Inc.
Conditions:
Huntington Disease
Eligibility:
All Genders
Phase:
PHASE1
Brief Summary
Huntington's disease (HD) is a fatal disease with profound neurological and behavioral features. HD is typically characterized by uncontrollable movements and psychological disturbances. This study w...
Detailed Description
Observations from our research studies indicate that, far infrared rays provide energy to the body, improve the autonomic functions of the nervous system, restore the functions of the endocrine system...
Eligibility Criteria
Inclusion
- People with HD
Exclusion
- None
Key Trial Info
Start Date :
May 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2010
Estimated Enrollment :
5 Patients enrolled
Trial Details
Trial ID
NCT00675077
Start Date
May 1 2008
End Date
June 1 2010
Last Update
January 5 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Centre for Incurable Diseases
Toronto, Ontario, Canada, M4V 1L5